1 Liang S,Xu Z,Xu X,et al.Quantitative proteomics for cancer biomarker discovery[J].Comb Chem High Throughput Screen,2012,15(3):221-231. 2 Reichenbach ZW,Murray MG,Saxena R,et al.Clinical and translational advancesin esophageal squamous cell carcinoma[J].Adv Cancer Res,2019,144:95-135. 3 Kumagai K,Rouvelas I,Tsai JA,et al.Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer:a direct and adjusted indirect comparison meta-analysis[J].Surg Oncol,2015,41(3):282-294. 4 Wang F,Liu S,Liu J,et al.SP promotes cell proliferation in esophageal squamous cell carcinoma through the NK1R/Hes1 axis[J].Biochem Biophys Res Commun,2019,514(4):1210-1216. 5 Ma XL,Yao H,Wang X,et al.ILK predicts the efficacy of chemoradiotherapy and the prognosis of patients with esophageal squamous cell carcinoma[J].Oncol Lett,2019,18(4):4114-4125. 6 Fernández-Coto DL,Gil J,Hernández A,et al.Quantitative proteomics reveals proteins involved in the progression from non-cancerous lesions to gastric cancer[J].Proteomics,2018,186:15-27. 7 Jiang Z,Sun X,Zhang Q,et al.Identification of candidate biomarkers that involved in the epigenetic transcriptional regulation for detection gastric cancer by iTRAQ based quantitative proteomic analysis[J].Clin Chim Acta,2017,471:29-37. 8 Yang Y,Toy W,Chong LY,et al.Discovery of SLC3A2 cell membrane protein as a potential gastric cancer biomarker:implications in molecular imaging[J].Proteome Res,2012,11(12):5736-5747. 9 Li BP,Mao YT,Wang Z,et al.CLIC1 promotes the progression of gastric cancer by regulating the MAPK/AKT pathways[J].Cell Physiol Biochem,2018,46(3):907-924. 10 Zhang X,Zhu Y,Duan W,et al.Allicin induces apoptosis of the MGC-803 humangastric carcinoma cell line through the p38 mitogen-activated proteinkinase/caspase-3 signaling pathway[J].Mol Med Rep,2015,11(4):2755-2760. 11 王浩冉,潘元明,张玲.大蒜素对胃癌细胞化疗增敏机制研究[J].世界华人消化杂志,2019,27(20):1248-1255. 12 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424. 13 Cheng J,Wu LM,Deng XS,et al.MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway[J].Hepatobiliary Pancreat Dis Int,2018,17(4):336-344. 14 Lin Q,Peng S,Yang Y.Inhibition of CD9 expression reduces the metastatic capacity of human hepatocellular carcinoma cell line MHCC97-H[J].Int J Oncol,2018,53(1):266-274. 15 Razumilava N,Gores GJ.Cholangiocarcinoma[J].Lancet,2014,383:2168-2179. 16 Eckel F,Schmid RM.Chemotherapy in advanced biliary tract carcinoma:a pooled analysis of clinical trials[J].Br J Cancer,2007,96(6):896-902. 17 Tang Z,Yang Y,Zhao Z,et al.The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma:a systematic review and meta-analysis[J].Medicine(Baltimore),2018,97(34):e11999. 18 Marin JJG,Lozano E,Briz O,et al.Molecular bases of chemoresistance in cholangiocarcinoma[J].Curr Drug Targets,2017,18(8):889-900. 19 Ren H,Luo M,Chen J,et al.Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ based quantitative proteomics analysis[J].Oncol Rep,2019,42(6):2622-2634. 20 Tang Z,Yang Y,Zhang J,et al.Quantitative proteomic analysis and evaluation of the potential prognostic biomarkers in cholangiocarcinoma[J].J Cancer,2019,10(17):3985-3999. 21 Siegel RL,Miller KD,Jemal A.Cancer statistics[J].CA Cancer J Clin,2019,69:7-34. 22 Liu XH,Zheng WM,Wang WS,et al.A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline[J].Brit J Cancer,2017,117(12):1846-1854. 23 Li H,Mao Y,Xiong Y,et al.Comprehensive proteome analysis of peripheral blood mononuclear cells(PBMCs)to identify candidate biomarkers of pancreatic cancer[J].Cancer Genomics Proteomics,2019,16(1):81-89. 24 李珊,赵春波,乔文波.术中放疗在胰腺癌中的应用进展[J].实用肿瘤学杂志,2019,33(3):280-283. 25 Lei S,He Z,Chen T,et al.Long noncoding RNA 00976 promotes pancreatic cancer progression through OTUD7B by sponging miR-137 involving EGFR/MAPK pathway[J].J Exp Clin Cancer Res,2019,38(1):470. 26 Bray F,Feday J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424. 27 方琳,刘超,张纯慧,等.转移性结直肠癌维持治疗的研究现状与治疗策略[J].实用肿瘤学杂志,2019,33(2):173-178. 28 Peng F,Huang Y,Li MY,et al.Dissecting characteristics and dynamics of differentially expressed proteins during multistage carcinogenesis of human colorectal cancer[J].World J Gastroenterol,2016,22(18):4515-4528. 29 Chen H,Xu L,Yin L,et al.iTRAQ-based proteomic analysis of dioscin on human HCT-116 colon cancer cells[J].Proteomics,2014,14(1):51-73. |